The First and Only Medicine for Parkinson's Disease Dementia is ... - Finanzen.net
FRIMLEY, England, May 24 /PRNewswire/ --
Exelon(R) (rivastigmine), the first and only medicine licenced for the treatment of mild to moderately severe dementia associated with idiopathic Parkinson's disease (PD) is now available.
Rivastigmine, already indicated for mild to moderately severe Alzheimer's disease (AD), is now the only medicine to be licensed for the treatment of Parkinson's disease dementia (PDD). Parkinson's disease is not merely a movement disorder. There are approximately 120,000 people with Parkinson's disease in the UK and at any one time, up to 40% of these patients will suffer from varying levels of dementia. It is one of the most distressing complications of PD for both patients and carers. Patients experience a wide range of symptoms, the most troublesome of which are often behavioural, such as hallucinations, anxiety, apathy and depression and it is these symptoms which often result in a patient having to go into a nursing home
· Read The Full Parkinson's Disease Article From No Source -->
·
Read All Parkinson's Disease News Stories -->